The standard dose of misoprostol for labor induction is 25 micrograms (µg), given either orally every 2 hours or vaginally every 6 hours. This is the dose recommended by the World Health Organization and supported by the largest body of clinical evidence. Your care team will determine the exact regimen based on how your cervix responds, but 25 µg is the starting point used in most hospitals today.
Recommended Doses by Route
Misoprostol can be given by mouth or placed vaginally, and the dosing schedule differs depending on the route. Oral misoprostol is typically given as a 25 µg dose every 2 hours. This timing is based on how the drug moves through your body: it reaches peak levels in about 30 minutes, sustains uterine activity for roughly 90 minutes, and is largely cleared within 2 hours. So each new dose picks up where the last one left off.
Vaginal misoprostol is also given at 25 µg but less frequently, every 6 hours, because the drug is absorbed more slowly and acts longer when placed directly against the cervix. A 2023 review published in the American Journal of Obstetrics & Gynecology found that 25 µg of vaginal misoprostol was the most effective method for reducing the time from intervention to delivery across multiple cervical ripening approaches, without increasing the odds of cesarean delivery, low Apgar scores, or uterine overstimulation.
Some published protocols use doses ranging from 10 µg to 50 µg, and older studies tested doses as high as 200 µg orally. In current practice, 25 to 50 µg is the typical range used in labor and delivery units. Evidence consistently favors starting at 25 µg for the best balance of effectiveness and safety.
Why 25 µg Is Preferred Over 50 µg
Doubling the dose to 50 µg does speed things up, but the trade-off is a sharp rise in complications. The main concern is tachysystole, a pattern of contractions that come too fast and too close together. When contractions pile up without adequate rest periods, the uterus can’t fully relax between them, which reduces blood flow to the baby.
In a systematic review comparing the two vaginal doses, the overall rate of tachysystole was 8.9% with 25 µg and 20.8% with 50 µg. The more dangerous version of this, called hyperstimulation syndrome (tachysystole combined with changes in the baby’s heart rate), occurred in 4.4% of the 25 µg group compared with 9.3% of the 50 µg group. That means the higher dose roughly doubled the risk of both complications. For this reason, most guidelines now recommend starting low.
When Misoprostol Is Used
Misoprostol is primarily used when the cervix isn’t yet ready for labor on its own. Providers assess cervical readiness using the Bishop score, a point system that evaluates how dilated, thinned, soft, and positioned the cervix is. A Bishop score below 6 generally means the cervix needs help ripening before contractions can do their job effectively.
Women with very low scores (3 or below) benefit the most from prostaglandin medications like misoprostol. At these scores, the cervix is firm, closed, and high, and simply starting an oxytocin drip is unlikely to lead to a vaginal delivery. Misoprostol softens and opens the cervix gradually, often triggering contractions in the process. Once the cervix reaches a more favorable state, oxytocin may or may not be added depending on how labor is progressing.
What Happens During the Process
After each dose of misoprostol, your baby’s heart rate and your contraction pattern will be monitored electronically for at least 30 minutes. If the monitoring shows tachysystole (contractions coming more than five times in 10 minutes), monitoring continues for at least 60 minutes, and the next dose may be delayed or skipped entirely. The goal is steady, progressive contractions, not overwhelming ones.
The time from the first dose to delivery varies widely. Some women respond within a few hours, especially if their cervix was already partially favorable. Others need multiple doses over 12 to 24 hours or longer. If misoprostol alone doesn’t produce adequate labor, your provider may add oxytocin or use a mechanical method like a Foley catheter balloon to continue the process.
Oral vs. Vaginal: How They Compare
Vaginal misoprostol tends to be more potent. It produces stronger uterine activity with the same dose, which makes it more effective at getting labor going but also slightly more likely to cause overstimulation. Oral misoprostol has a safety profile closer to that of dinoprostone (the other prostaglandin commonly used for cervical ripening) and gives providers more control because of the shorter dosing intervals. If contractions become too intense with the oral route, the next dose is simply held and the effect fades relatively quickly.
Some hospitals use a titrated oral solution, where misoprostol is dissolved in water and given in carefully measured small doses (as low as 20 µg) every 1 to 2 hours. This approach allows even finer control over contraction strength and frequency, though it requires more hands-on management by nursing staff. The choice between oral and vaginal often comes down to institutional preference and individual clinical circumstances.
Who Should Not Receive Misoprostol
The most important contraindication is a prior cesarean section or other uterine surgery. Misoprostol significantly increases the risk of uterine rupture in women with a uterine scar. In second-trimester inductions, the rupture rate with a prior cesarean was 1.1%, compared to 0.01% in women without a prior cesarean, a roughly 100-fold difference. Of the ruptures that occurred in that analysis, some required emergency hysterectomy. For term labor induction, the concern is the same, and most guidelines explicitly prohibit misoprostol use in women with a scarred uterus.
Other contraindications include known allergy to prostaglandins and situations where vaginal delivery itself is not safe, such as placenta previa or certain fetal positions. Women with a history of more than five prior deliveries may also face higher risks from any prostaglandin agent due to increased susceptibility to uterine overstimulation.
Common Side Effects
Beyond uterine overstimulation, misoprostol can cause nausea, diarrhea, vomiting, and fever or chills. These are generally mild and resolve on their own. Diarrhea is more common with oral and sublingual routes. Fever tends to be low-grade and short-lived, but your team will monitor it to rule out infection. The most clinically significant side effect remains tachysystole, which at the 25 µg dose occurs in roughly 1 in 11 women and is usually manageable by pausing further doses and, if needed, giving medication to relax the uterus.